🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A multinational, multicenter, randomized, double-blind, study in areas of h...
Status
Terminated
Location
Sanofi-Aventis
Start Date
2005-11
Trial ID
NCT00237445
Treatments Being Tested
CCTG 590 is a open-label study to evaluate the impact of therapy intensific...
Status
Completed
Location
University Southern California
Start Date
2008-10-20
Trial ID
NCT00925756
Treatments Being Tested
New antibiotics are required that have antibacterial activity against doxyc...
Status
Completed
Location
Chosun University Hospital
Start Date
2005-09
Trial ID
NCT00351182
Treatments Being Tested
Primary Objectives: * The primary objective of the study is to evaluate cl...
Status
Completed
Location
Multiple Locations
Start Date
2005-02
Trial ID
NCT00261105
Treatments Being Tested
This is a multinational, randomized (1:1), double-blind, double-dummy, comp...
Status
Terminated
Location
Sanofi-Aventis
Start Date
2006-01
Trial ID
NCT00315003
Treatments Being Tested
The primary objective is to assess the safety of telithromycin (HMR3647) 20...
Status
Completed
Location
Sanofi-Aventis
Start Date
2004-02
Trial ID
NCT00638534
Treatments Being Tested
Studies have previously shown that a broad drug interaction screening can b...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00164112
The primary objective is to assess the safety of telithromycin (HMR3647) 20...
Status
Completed
Location
Sanofi-Aventis
Start Date
2004-03
Trial ID
NCT00638859
Treatments Being Tested
The major objectives of this research are to see how much, and for how long...
Status
Terminated
Location
Pulmonary Associates PA
Start Date
2006-01
Trial ID
NCT00315601
Treatments Being Tested
The primary objective is to assess the safety of telithromycin (HMR 3647) (...
Status
Completed
Location
Sanofi-Aventis
Start Date
2004-08
Trial ID
NCT00408135
Treatments Being Tested